Merck (MRK) Tops Q3 EPS by 23c; narrows forecast
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $135.84 --0%
Financial Fact:
Total Costs, Expenses and Other: 12.82B
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Total Costs, Expenses and Other: 12.82B
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Merck (NYSE: MRK) reported Q3 EPS of $2.58, $0.23 better than the analyst estimate of $2.35. Revenue for the quarter came in at $17.28 billion versus the consensus estimate of $16.98 billion.
GUIDANCE:
Merck sees FY2025 EPS of $8.93-$8.98, versus the consensus of $8.89. Merck sees FY2025 revenue of $64.5-65 billion, versus the consensus of $64.81 billion.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- INVO Fertility (IVF) Tops Q2 EPS by 105c
- Bonk, Inc. posts $5.5M revenue in H1 2026, reports $7.88M net loss
- Trump threatens to bomb Oman over Iran stance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
